Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |